* OPKO Health Inc reported a quarterly adjusted loss of 12 cents per share for the quarter ended in March, lower than the same quarter last year, when the company reported EPS of -2 cents. The mean expectation of six analysts for the quarter was for a loss of 9 cents per share. Wall Street expected results to range from -14 cents to -6 cents per share.
* Revenue fell 26.9% to $173.70 million from a year ago; analysts expected $182.99 million.
* OPKO Health Inc's reported EPS for the quarter was a loss of 12 cents.
* The company reported a quarterly loss of $81.8 million.
* OPKO Health Inc shares had risen by 10.0% this quarter and lost 12.6% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 46.2% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for OPKO Health Inc is $4.00 This summary was machine generated from LSEG data May 7 at 09:22 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.09 -0.12 Missed
Dec. 31 2023 -0.09 -0.09 Met
Sep. 30 2023 -0.10 -0.11 Missed
Jun. 30 2023 -0.07 -0.03 Beat
Comments